Androgenetic alopecia in women.
4/5 보강
TL;DR
The diagnosis of androgenetic alopecia in women is supported by early age of onset, the pattern of increased thinning over the frontal/parietal scalp with greater density over the occipital scalp, retention of the frontal hairline, and the presence of miniaturized hairs.
📑 코퍼스 인용 관계
· 인용됨 40
📑 인용한 논문 (6) ▾
- Relative efficacy of minoxidil in combination with other treatments for androgenic alopeci… Frontiers in medicine · 2025
- Topical dutasteride for androgenic alopecia: current state and prospects. Therapeutic delivery · 2025
- Hypertrichosis Induced by Minoxidil: A Case of Systemic Absorption from Scalp Occlusion. The American journal of case reports · 2025
- Advances in Transdermal Delivery Systems for Treating Androgenetic Alopecia. Pharmaceutics · 2025
- Short-Term Clinical Assessment of Treating Female Androgenetic Alopecia with Autologous St… Biomedicines · 2024
- Androgenetic Alopecia in Men: An Update On Genetics. Indian journal of dermatology · 2024
연도별 인용 (2012–2026) · 합계 161
OpenAlex 토픽 ·
Hair Growth and Disorders
Cancer and Skin Lesions
Abstract 🌐 Abstract
Androgenetic alopecia (AGA), also known in women as female pattern hair loss, is caused by androgens in genetically susceptible women and men. The thinning begins between ages 12 and 40 years, the inheritance pattern is polygenic, and the incidence is the same as in men. In susceptible hair follicles, dihydrotestosterone binds to the androgen receptor, and the hormone-receptor complex activates the genes responsible for the gradual transformation of large terminal follicles to miniaturized follicles. Both young women and young men with AGA have higher levels of 5alpha reductase and androgen receptor in frontal hair follicles compared to occipital follicles. At the same time, young women have much higher levels of cytochrome p-450 aromatase in frontal follicles than men who have minimal aromatase, and women have even higher aromatase levels in occipital follicles. The diagnosis of AGA in women is supported by early age of onset, the pattern of increased thinning over the frontal/parietal scalp with greater density over the occipital scalp, retention of the frontal hairline, and the presence of miniaturized hairs. Most women with AGA have normal menses and pregnancies. Extensive hormonal testing is usually not needed unless symptoms and signs of androgen excess are present such as hirsutism, severe unresponsive cystic acne, virilization, or galactorrhea. Topical minoxidil solution is the only drug available for promoting hair growth in women with AGA. Efficacy has been shown in double-blind studies using hair counts and hair weight.
The diagnosis of androgenetic alopecia in women is supported by early age of onset, the pattern of increased thinning over the frontal/parietal scalp with greater density over the occipital scalp, ret
APA 7
Price, V. H. (2003). Androgenetic alopecia in women.. The journal of investigative dermatology. Symposium proceedings, 8(1), 24-7. https://doi.org/10.1046/j.1523-1747.2003.12168.x
Vancouver
Price VH. Androgenetic alopecia in women. jour. inve. derm. Symp. proc.. 2003;8(1):24-7. doi:10.1046/j.1523-1747.2003.12168.x
AMA 11
Price VH. Androgenetic alopecia in women. jour. inve. derm. Symp. proc.. 2003;8(1):24-7. doi:10.1046/j.1523-1747.2003.12168.x
Chicago
Price, V. H.. 2003. "Androgenetic alopecia in women." The journal of investigative dermatology. Symposium proceedings 8 (1): 24-7. https://doi.org/10.1046/j.1523-1747.2003.12168.x
MLA 9
Price, V. H.. "Androgenetic alopecia in women." The journal of investigative dermatology. Symposium proceedings, vol. 8, no. 1, 2003, pp. 24-7. doi:10.1046/j.1523-1747.2003.12168.x.
PMID
12894991 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 8/8 (100%)
· 참조 0편 · 후속 8편
이 논문을 인용한 후속 연구 20
- Androgenetic Alopecia: Therapy Update.
- Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria.
- Female pattern alopecia: current perspectives.
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.
- Hair Regenerative Mechanisms of Red Ginseng Oil and Its Major Components in the Testosterone-Induced…
- Quality of Life Assessment in Patients with Androgenetic Alopecia.
- Interventions for female pattern hair loss.
- Parietal scalp is another affected area in female pattern hair loss: an analysis of hair density and…
- The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia.
- Protective Role of Nutritional Plants Containing Flavonoids in Hair Follicle Disruption: A Review.
- Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhan…
- CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD.
- An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% M…
- Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive huma…
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias.
- Intermediate Hair Follicles from Patients with Female Pattern Hair Loss Are Associated with Nutrient…
- Prostaglandin D2-Mediated DP2 and AKT Signal Regulate the Activation of Androgen Receptors in Human …
- Epidemiology and disease burden of androgenetic alopecia in college freshmen in China: A population-…
- Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgeneti…
- Hormonal therapy in female pattern hair loss.
같은 제1저자의 인용 많은 논문 (5)
- Treatment of hair loss.
- Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
- Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.